4176 - 4200 of 6516 Results
Title
Year
-
OPENTitle: Basal Synaptic Transmission and Long-Term Plasticity at CA3-CA1 Synapses Are Unaffected in Young Adult PINK1-Deficient RatsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 655901End Page: 655901Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.655901Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.655901/pdfCitation Count: 2
- miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease2020OPENTitle: miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 140Issue #: 3Start Page: 295End Page: 315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-020-02185-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8414561Citation Count: 39
-
OPENTitle: Altered Brain Functional Network in Subtypes of Parkinson's Disease: A Dynamic PerspectiveJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 710735End Page: 710735Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.710735Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.710735/pdfCitation Count: 30
-
OPENTitle: Accelerating Medicines Partnership: Parkinson's Disease. Genetic ResourceJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1795End Page: 1804Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28549Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28549Citation Count: 127
- Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study2021OPENTitle: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1853End Page: 1862Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28596Citation Count: 40
-
OPENTitle: Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegenerationJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 4Start Page: e1010138End Page: e1010138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1010138Best OA location URL: https://doi.org/10.1371/journal.pgen.1010138Citation Count: 9
-
OPENTitle: Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo‐Controlled Trial of RasagilineJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 325End Page: 333Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28838Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9019575Citation Count: 16
-
OPENTitle: Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 804261End Page: 804261Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.804261Best OA location URL: https://doi.org/10.3389/fnins.2022.804261Citation Count: 16
-
OPENTitle: Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 4Start Page: e0266405End Page: e0266405Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0266405Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0266405&type=printableCitation Count: 5
- Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies2021OPENTitle: Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathiesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 2Start Page: 584End Page: 595Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab431Best OA location URL: https://academic.oup.com/brain/article-pdf/145/2/584/43402317/awab431.pdfCitation Count: 179
-
OPENTitle: Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer’s disease-associated genetic variantsJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 163End Page: 163Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41398-022-01913-1Best OA location URL: https://doi.org/10.1038/s41398-022-01913-1Citation Count: 25
- The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity2022OPENTitle: The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicityJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202010065Best OA location URL: https://escholarship.org/uc/item/4764f6j3Citation Count: 18
-
OPENTitle: Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson´s DiseaseJournal Name: Frontiers in GeneticsPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 781816End Page: 781816Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fgene.2022.781816Best OA location URL: https://www.frontiersin.org/articles/10.3389/fgene.2022.781816/pdfCitation Count: 10
-
OPENTitle: SNCA rs3910105 Is Associated With Development of Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 832550End Page: 832550Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.832550Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.832550/pdfCitation Count: 3
-
OPENTitle: CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 834580End Page: 834580Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834580Best OA location URL: https://doi.org/10.3389/fneur.2022.834580Citation Count: 36
-
OPENTitle: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)Journal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 2Start Page: e052032End Page: e052032Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/2/e052032.full.pdfCitation Count: 12
-
OPENTitle: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 8Start Page: e859End Page: e871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013218Best OA location URL: https://n.neurology.org/content/neurology/98/8/e859.full.pdfCitation Count: 186
-
OPENTitle: Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00285-zBest OA location URL: https://www.nature.com/articles/s41531-022-00285-z.pdfCitation Count: 10
-
OPENTitle: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome ActivationJournal Name: International Journal of InflammationPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/2337363Best OA location URL: https://downloads.hindawi.com/journals/iji/2022/2337363.pdfCitation Count: 11
-
OPENTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: https://doi.org/10.1016/j.omtn.2022.02.007Citation Count: 24
-
OPENTitle: Trends in the Utilization of Teleneurology and Other Healthcare Resources Prior to and During the COVID-19 Pandemic in an Urban, Tertiary Health SystemJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 834708End Page: 834708Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834708Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.834708/pdfCitation Count: 14
-
OPENTitle: Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 838674End Page: 838674Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.838674Best OA location URL: https://doi.org/10.3389/fnagi.2022.838674Citation Count: 8
-
OPENTitle: Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease PatientsJournal Name: MetabolitesPublisher: MDPI AGVol: 12Issue #: 2Start Page: 149End Page: 149Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo12020149Best OA location URL: https://www.mdpi.com/2218-1989/12/2/149/pdf?version=1645608748Citation Count: 17
-
OPENTitle: Regional transcriptional architecture of Parkinson’s disease pathogenesis and network spreadJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3072End Page: 3085Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz223Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3072/30071482/awz223.pdfCitation Count: 40
-
OPENTitle: True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretationJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 48Issue #: 8Start Page: 2416End Page: 2425Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-05151-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8891344Citation Count: 56